X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (169) 169
female (130) 130
male (129) 129
cardiac & cardiovascular systems (112) 112
aged (111) 111
middle aged (109) 109
abridged index medicus (79) 79
risk factors (78) 78
heart attacks (64) 64
acute coronary syndromes (59) 59
care and treatment (55) 55
treatment outcome (54) 54
cardiovascular (48) 48
double-blind method (48) 48
mortality (48) 48
electrocardiography (46) 46
heart failure (40) 40
cardiology (38) 38
cardiac patients (36) 36
coronary heart disease (36) 36
analysis (35) 35
prognosis (35) 35
risk (34) 34
acute coronary syndrome (33) 33
risk assessment (33) 33
myocardial infarction (32) 32
acute coronary syndrome - drug therapy (31) 31
diabetes (31) 31
patient outcomes (31) 31
time factors (31) 31
myocardial infarction - mortality (30) 30
ranolazine (30) 30
heart attack (29) 29
ischemia (29) 29
internal medicine (28) 28
myocardial infarction - drug therapy (28) 28
clinical trials (27) 27
drug therapy (27) 27
cardiovascular disease (26) 26
myocardial-infarction (26) 26
peripheral vascular disease (26) 26
clopidogrel (25) 25
follow-up studies (25) 25
outcomes (25) 25
platelet aggregation inhibitors - therapeutic use (25) 25
kaplan-meier estimate (24) 24
cardiovascular diseases (23) 23
myocardial infarction - diagnosis (23) 23
patients (23) 23
usage (23) 23
biomarkers - blood (21) 21
cardiology and cardiovascular medicine (21) 21
dosage and administration (21) 21
medical colleges (21) 21
research (21) 21
acute coronary syndrome - mortality (20) 20
biomarkers (20) 20
events (20) 20
health aspects (20) 20
incidence (20) 20
acute myocardial-infarction (19) 19
atherosclerosis (19) 19
diabetes mellitus (19) 19
piperazines - therapeutic use (19) 19
secondary prevention (19) 19
management (18) 18
studies (18) 18
aged, 80 and over (17) 17
angina pectoris (17) 17
aspirin (17) 17
cardiac arrest (17) 17
complications and side effects (17) 17
diabetes mellitus, type 2 - drug therapy (17) 17
hospitalization (17) 17
registries (17) 17
stroke (17) 17
clinical outcomes (16) 16
diabetes mellitus, type 2 - complications (16) 16
proportional hazards models (16) 16
prospective studies (16) 16
ticlopidine - analogs & derivatives (16) 16
unstable angina (16) 16
acetanilides - therapeutic use (15) 15
adamantane - analogs & derivatives (15) 15
adult (15) 15
death (15) 15
lactones - therapeutic use (15) 15
medicine, general & internal (15) 15
pyridines - therapeutic use (15) 15
acute coronary syndrome - diagnosis (14) 14
coronary vessels (14) 14
myocardial infarction - blood (14) 14
natriuretic peptides (14) 14
platelet aggregation inhibitors - adverse effects (14) 14
recurrence (14) 14
acute coronary syndrome - physiopathology (13) 13
heart diseases (13) 13
heart-failure (13) 13
myocardial infarction - epidemiology (13) 13
percutaneous coronary intervention (13) 13
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England journal of medicine, ISSN 1533-4406, 2012, Volume 366, Issue 15, pp. 1404 - 1413
Patients with atherosclerotic vascular disease were randomly assigned to receive the thrombin antagonist vorapaxar or placebo. Vorapaxar reduced the rate of... 
ATOPAXAR | MEDICINE, GENERAL & INTERNAL | CLOPIDOGREL | EFFICACY | SAFETY | TOLERABILITY | DOUBLE-BLIND | PRASUGREL | LESSONS | ANTAGONISTS | ASPIRIN | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Male | Risk | Secondary Prevention | Pyridines - adverse effects | Cardiovascular Diseases - mortality | Female | Platelet Aggregation Inhibitors - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Pyridines - therapeutic use | Double-Blind Method | Hemorrhage - epidemiology | Receptor, PAR-1 - antagonists & inhibitors | Kaplan-Meier Estimate | Peripheral Arterial Disease - drug therapy | Stroke - drug therapy | Lactones - adverse effects | Lactones - therapeutic use | Retreatment | Myocardial Infarction - drug therapy | Brain Ischemia - drug therapy | Intracranial Hemorrhages - chemically induced | Intracranial Hemorrhages - epidemiology | Aged | Hemorrhage - chemically induced | Prevention | Drugs | Aggregation | Dose-response relationship (Biochemistry) | Atheroembolism | Blood platelets | Atherosclerosis | Product/Service Evaluations | Dosage and administration | Drug therapy | Myocardial infarction | Cerebral infarction | Stroke | Aspirin | Heart attacks | Proteinase-activated receptor 1 | Thrombin | Hemorrhage | Patients | Bleeding | Disease prevention | Ischemia | Arteriosclerosis | Death | Cardiovascular diseases | Health risk assessment | Computer Science | Medical Imaging
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2008, Volume 371, Issue 9621, pp. 1353 - 1363
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2018, Volume 379, Issue 12, pp. 1107 - 1117
Journal Article
Journal Article
American Heart Journal, ISSN 0002-8703, 2009, Volume 158, Issue 3, pp. 335 - 341.e3
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 2012, Volume 60, Issue 17, pp. 1623 - 1630
Journal Article
American Heart Journal, ISSN 0002-8703, 2011, Volume 162, Issue 5, pp. 818 - 825.e6
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2016, Volume 67, Issue 17, pp. 1981 - 1990
Journal Article